ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 301457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 301457; 2) Community: the network communities that were significantly associated with the response to NSC 301457; 3) Molecule: the relationships between components within communities and NSC 301457; 4) MDR: the compounds that were significantly associated with the NSC 301457.

NSC Compound Enrichment Correlation
NSC 732698 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne 0.00741876119839033 0.5441643
NSC 745813 Null 0.00741876119839033 0.46165337
NSC 605607 Null 0.00792181575650994 0.60851236
NSC 607088 Null 0.00792181575650994 0.38041605
NSC 617668 DOLASTATIN 15 0.00792181575650994 0.42799407
NSC 629749 .beta.-Lapachone 0.00792181575650994 0.31868006
NSC 648365 Insulin-Methotrexate conjugate 0.00792181575650994 0.27893722
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.00792181575650994 -0.084367449
NSC 666571 7.alpha.-Methyl-3,11.beta.,17.beta.-trihydroxy estra-1,3,5(10)triene 11-nitrate ester 0.00792181575650994 0.2959216
NSC 671660 Null 0.00792181575650994 0.68217302
Total:96  Current:22    [First] [Prev] [Next] [Last]